Rebecca Steele
Secretariat at European Alliance for Value in Health- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
European Alliance for Value in Health
-
Belgium
-
Non-profit Organizations
-
1 - 100 Employee
-
Secretariat
-
Sep 2021 - Present
Providing the secretariat to the European Alliance for Value in HealthThe European Alliance for Value in Health is a group of associations representing stakeholders active in the broader European health systems.The VISION of the Alliance for Value in Health is a Europe, where health systems are value-based, sustainable, and people-centred. Our MISSION is to partner to facilitate health system transformation, by disseminating knowledge and best practices, and engaging with policymakers and stakeholders – at European, national, and regional levels.
-
-
-
Vintura
-
Netherlands
-
Business Consulting and Services
-
1 - 100 Employee
-
Consultant
-
Jun 2021 - Present
Life sciences consultant, working across Market Access, Commercial Strategy and Policy. At Vintura, our mission is 'creating meaningful impact in healthcare together'. We apply our expertise to help organisations in the pharmaceutical sector and hospitals bring about ongoing improvement. Life sciences consultant, working across Market Access, Commercial Strategy and Policy. At Vintura, our mission is 'creating meaningful impact in healthcare together'. We apply our expertise to help organisations in the pharmaceutical sector and hospitals bring about ongoing improvement.
-
-
-
Charles River Associates
-
United States
-
Business Consulting and Services
-
700 & Above Employee
-
Associate
-
Sep 2019 - May 2021
Working on projects across commercial & P&MA strategy, plus health policyExperience across EU markets, US, Canada and Australia, with some work within emerging marketsParticular interests include solving complex challenges associated with high-cost innovative therapies, including potentially curative cell & gene therapies. Such as:- P&MA with novel pricing and payment models/ MEAs to mitigate budget impact- Enabling access (cross-border care with limited treatment centers, enabling early access)- Identifying the commercial opportunity for cell & gene therapies- Policy shaping towards a more favourable environment (writing white papers on challenges and policy solutions, e.g. overcoming access issues for high-cost oncology combination therapies; a paper which was recently presented at ESMO)
-
-
Analyst
-
Oct 2018 - Sep 2019
-
-
-
-
Venture Catalyst Challenge Finalist
-
Jan 2018 - Mar 2018
A program to test the commercial viability of early-stage science and technology ideas, resulting in a pitch competition.
-
-
WE Innovate Programme Finalist
-
Oct 2017 - Mar 2018
Third place prize winner (of 40+ teams) of the WE Innovate Entrepreneurship competition.WE Innovate is a 6-month STEM-based female-led entrepreneurship competition for members of Imperial College London. Our 4-person team grew our business from conception to a thoroughly planned and tested idea, with a detailed business plan and financial model. We successfully progressed through to Phase II, then to the final. I led the pitch in the final, winning the £5000 third place prize.
-
-
Education
-
The London School of Economics and Political Science (LSE)
MBA Essentials, Business Administration and Management, General -
Imperial College London
Masters by Research - MRes, Systems and Synthetic Biology -
SynbiCITE
Short-course MBA -
University of Bristol
Biochemistry, 2.1 -
Guildford High School